StratDeck

Two stocks in Healthcare

Eli Lilly and Company vs McKesson: profit, growth, debt and price compared

Eli Lilly and Company is stronger on 3 of 6 figures: profit margin, sales growth and dividend. McKesson is stronger on 2: price for its expected profit and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Eli Lilly and Company's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Eli Lilly and Company and McKesson side by side
Eli Lilly and CompanyLLYMcKessonMCK
Net marginStronger: 31.9%1.1%
Revenue growth, past yearStronger: +38.61%+7.57%
Debt to equity122.9%—
Forward P/E27.2×Stronger: 20.7×
Dividend yieldStronger: 0.49%0.31%
AnalystsBuy · 29Buy · 14
From its 200-day average+21.2%Stronger: +22.8%

Share price over the past year

  • Eli Lilly and Company+34.2%
  • McKesson+26.0%

18 Nov 202518 Nov 2026

Eli Lilly and Company or McKesson: which is stronger?

  • LLY

    Which is more profitable?

    Eli Lilly and Company keeps more of each sale as profit: 31.9% against 1.1%.

  • LLY

    Which is growing its sales faster?

    Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +7.57%.

  • MCK

    Which costs less for the profit it is expected to make?

    McKesson costs less for the profit it is expected to make: 20.7× its forward earnings, against 27.2×.

  • LLY

    Which pays more in dividends?

    Eli Lilly and Company pays more back in dividends for what a share costs: 0.49% a year, against 0.31%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • MCK

    Which is in the stronger price trend?

    McKesson's price is in the stronger trend: 22.8% above its 200-day average, against 21.2% above.

What each company does

LLYEli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Reports results on 3 February 2027

MCKMcKesson

McKesson Corporation provides healthcare services in the United States and internationally.

Reports results on 3 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.